Communication Issues in Patient and Provider Discussions of Immunotherapy
Recruiting
N/A
Interventional Study
Hematopoietic and Lymphoid System Neoplasm
Malignant Solid Neoplasm
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 125 (estimated)
- Sponsor
- Emory University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This trials studies communication issues in patient and provider discussions about immunotherapy. The goal of this study is to describe where patients have heard about immunotherapy, what the participants understand about it, how physicians and other healthcare workers describe immunotherapy, and how educational videos may support patient knowledge about immunotherapy.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* AIMS 1-3: All patients and providers who may have a discussion about immunotherapy at the Winship Cancer Institute
* AIM 4: Any cancer patient
Contacts